Chromosome arm 3p has been widely recognized to harbor one or more tumor suppressor genes important in the development or progression of lung cancer. The minimally deleted region is quite extensive however, including over 60% of the short arm from 3p14 to p23 in SCLC. In non-SCLC, the minimally deleted region is smaller but less well defined; it appears to center around the 3p14 locus D3S3. Recent identification of an SCLC cell line with a submicroscopic deletion, the U2020 cell line, affords an opportunity to intensively investigate one small region of 3p for the presence of lung cancer associated tumor suppressor genes. the U2020 deletion is estimated to remove 4 to 5 megabases of 3p including the 3p14 locus D3S3. We have identified 7 additional markers deleted in U2020 and physically linked most of them over a region of 3.5 megabases. We have isolated yeast artificial chromosome (YAC) clones for all these markers and assembled many into contiguous cloned segments. the 33 YACs isolated so far contain about 4 megabases of the U2020 deletion. This proposal will use these YAC resources to develop a series of highly polymorphic markers along the U2020 deletion, and other selected regions of 3p. These polymorphic markers will then be used to survey lung tumors for loss of heterozygosity or small, homozygous or overlapping deletions. Tumors available for this analysis include up to 500 matched tumor-normal samples comprising non-SCLC cases and up to 200 unmatched SCLC cell lines. the primary aim of this proposal is to significantly narrow the target region within U2020 to uncover the location of one putative lung cancer tumor suppressor gene. this project will lay the foundation for future isolation and intensive study of this critically important tumor suppressor.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA058187-01
Application #
3796262
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Kimball, Abigail K; Oko, Lauren M; Bullock, Bonnie L et al. (2018) A Beginner's Guide to Analyzing and Visualizing Mass Cytometry Data. J Immunol 200:3-22
Tippimanchai, Darinee D; Nolan, Kyle; Poczobutt, Joanna et al. (2018) Adenoviral vectors transduce alveolar macrophages in lung cancer models. Oncoimmunology 7:e1438105
DeHart, David N; Lemasters, John J; Maldonado, Eduardo N (2018) Erastin-Like Anti-Warburg Agents Prevent Mitochondrial Depolarization Induced by Free Tubulin and Decrease Lactate Formation in Cancer Cells. SLAS Discov 23:23-33
Ren, Shengxiang; Zhang, Shucai; Jiang, Tao et al. (2018) Early detection of lung cancer by using an autoantibody panel in Chinese population. Oncoimmunology 7:e1384108
Davies, Kurtis D; Le, Anh T; Sheren, Jamie et al. (2018) Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples. J Thorac Oncol 13:1474-1482
Iams, Wade T; Yu, Hui; Shyr, Yu et al. (2018) First-line Chemotherapy Responsiveness and Patterns of Metastatic Spread Identify Clinical Syndromes Present Within Advanced KRAS Mutant Non-Small-cell Lung Cancer With Different Prognostic Significance. Clin Lung Cancer 19:531-543
McDaniel, Nellie K; Cummings, Christopher T; Iida, Mari et al. (2018) MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents. Mol Cancer Ther 17:2297-2308
Ghosh, Moumita; Miller, York E; Vandivier, R William et al. (2018) Reply to Sohal: Airway Basal Cell Reprogramming and Epithelial-Mesenchymal Transition: A Potential Key to Understanding Early Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 197:1645-1646
Ghosh, Moumita; Miller, York E; Nakachi, Ichiro et al. (2018) Exhaustion of Airway Basal Progenitor Cells in Early and Established Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 197:885-896
Farago, Anna F; Taylor, Martin S; Doebele, Robert C et al. (2018) Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring an NTRK Gene Fusion. JCO Precis Oncol 2018:

Showing the most recent 10 out of 435 publications